recombinant human igg1 monoclonal antibody cixutumumab formerly imc-a12 (ImClone Inc)
90
Structured Review
ImClone Inc
recombinant human igg1 monoclonal antibody cixutumumab formerly imc-a12

Recombinant Human Igg1 Monoclonal Antibody Cixutumumab Formerly Imc A12, supplied by ImClone Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imc-a12+antibody/imc+a12+antibody/pmc09955633-107-0-8
Average 90 stars, based on 1 article reviews

Recombinant Human Igg1 Monoclonal Antibody Cixutumumab Formerly Imc A12, supplied by ImClone Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imc-a12+antibody/imc+a12+antibody/pmc09955633-107-0-8
Average 90 stars, based on 1 article reviews
recombinant human igg1 monoclonal antibody cixutumumab formerly imc-a12 - by Bioz Stars,
2026-08
90/100 stars
Images
1) Product Images from "Potential Molecular Targeted Therapy for Unresectable Hepatocellular Carcinoma"
Article Title: Potential Molecular Targeted Therapy for Unresectable Hepatocellular Carcinoma
Journal: Current Oncology
doi: 10.3390/curroncol30020105
Figure Legend Snippet: Clinical trials on targeted therapy in hepatocellular carcinoma recurrence.
Techniques Used: Clinical Proteomics, Virus, Infection